Skip to main content
Fig. 2 | BMC Surgery

Fig. 2

From: Prediction of surgical resectability after FOLFIRINOX chemotherapy for borderline resectable and locally advanced pancreatic cancer (PeRFormanCe): a multicenter prospective trial - trial protocol

Fig. 2

Flowchart data analysis. WP: Work Package; BR: Borderline resectable pancreatic ductal adenocarcinoma; LA: Locally advanced pancreatic ductal adenocarcinoma; PDAC: Pancreatic ductal adenocarcinoma; BMI: Body mass index; CT: Computed Tomography; MRI: Magnetic resonance imaging; cfDNA: Cell free DNA; cfRNA: Cell free RNA

Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us